LANSOPRAZOLE | A202319 | PERRIGO R AND D CO
Highest NADAC/Unit
$0.4628
per ea
Lowest NADAC/Unit
$0.4628
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 70677110301FT ACID REDUCER DR 15 MG CAP | $0.4628 | EA | Generic | — | 2026-06-17 |
| 70677110302FT ACID REDUCER DR 15 MG CAP | $0.4628 | EA | Generic | — | 2026-06-17 |
| 45802087801LANSOPRAZOLE DR 15 MG CAPSULE | $0.4628 | EA | Generic | — | 2026-06-17 |
| 45802087802LANSOPRAZOLE DR 15 MG CAPSULE | $0.4628 | EA | Generic | — | 2026-06-17 |
| 45802087803LANSOPRAZOLE DR 15 MG CAPSULE | $0.4628 | EA | Generic | — | 2026-06-17 |
| 00113111401GS LANSOPRAZOLE DR 15 MG CAP | $0.4628 | EA | Generic | — | 2026-06-17 |
| 00113111402GS LANSOPRAZOLE DR 15 MG CAP | $0.4628 | EA | Generic | — | 2026-06-17 |
| 00113111403GS LANSOPRAZOLE DR 15 MG CAP | $0.4628 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.